BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang P, Feng J, Wu X, Chu W, Zhang Y, Li P. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases. Pathol Oncol Res 2021;27:588532. [PMID: 34257537 DOI: 10.3389/pore.2021.588532] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Hamdy H, Yang Y, Cheng C, Liu Q. Identification of Potential Hub Genes Related to Aflatoxin B1, Liver Fibrosis and Hepatocellular Carcinoma via Integrated Bioinformatics Analysis. Biology 2023;12:205. [DOI: 10.3390/biology12020205] [Reference Citation Analysis]
2 Lei Wang, Manman Qiu, Lili Wu, Zexing Li, Xinyi Meng, Lu He, Bing Yang. Construction and validation of prognostic signature for hepatocellular carcinoma basing on hepatitis B virus related specific genes. Infect Agent Cancer 2022;17:60. [PMID: 36474267 DOI: 10.1186/s13027-022-00470-y] [Reference Citation Analysis]
3 Wang Z, Zhang L, Xu J, Song W. Integrated analysis of ferroptosis-related gene signature for overall survival prediction in Asian patients with hepatocellular carcinoma. Clin Transl Oncol 2022. [DOI: 10.1007/s12094-022-02977-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kakar MU, Mehboob MZ, Akram M, Shah M, Shakir Y, Ijaz HW, Aziz U, Ullah Z, Ahmad S, Ali S, Yin Y, Li K. Identification of Differentially Expressed Genes Associated with the Prognosis and Diagnosis of Hepatocellular Carcinoma by Integrated Bioinformatics Analysis. BioMed Research International 2022;2022:1-12. [DOI: 10.1155/2022/4237633] [Reference Citation Analysis]
5 Xiong J, Wu R, He A, Hou P, Wang J, Zhang R, Liao W, Wu L, Li E. Comprehensive analysis of the effects of KIF2C on prognosis, biological functions and immune infiltration in PAAD. Tissue and Cell 2022;78:101900. [DOI: 10.1016/j.tice.2022.101900] [Reference Citation Analysis]
6 Ho PT, Balzanelli MG, Distratis P, Lazzaro R, Tran DK, Nguyen KCD, Bui TM, Nguyen TT, Pham ST, Nguyen HSD, Tran VT, Ho TT, Dipalma G, Inchingolo F, Quek C, Pham HT, Isacco CG, Santacroce L, Pham VH. Characteristics of Hepatitis B Virus Genotype and Sub-Genotype in Hepatocellular Cancer Patients in Vietnam. Diagnostics (Basel) 2022;12:2393. [PMID: 36292082 DOI: 10.3390/diagnostics12102393] [Reference Citation Analysis]
7 Yin X, Li J, Hao Z, Ding R, Qiao Y. A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology. Front Cell Infect Microbiol 2022;12:964469. [DOI: 10.3389/fcimb.2022.964469] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lin Z, Huang X, Ji X, Tian N, Gan Y, Ke L. Analysis of multiple databases identifies crucial genes correlated with prognosis of hepatocellular carcinoma. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-13159-4] [Reference Citation Analysis]
9 Taowen P, Shuyuan F, Xiaoli S, Annan W, Feng Q, Yizhong Z, Jing L, Bin L, Kun L, Yunpeng D. Study on the action mechanism of the peptide compounds of Wuguchong on diabetic ulcers, based on UHPLC-Q-TOF-MS, network pharmacology and experimental validation. J Ethnopharmacol 2022;:114974. [PMID: 35033625 DOI: 10.1016/j.jep.2022.114974] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]